BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20389298)

  • 1. Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies.
    Bao Y; Ng K; Wolpin BM; Michaud DS; Giovannucci E; Fuchs CS
    Br J Cancer; 2010 Apr; 102(9):1422-7. PubMed ID: 20389298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.
    Ng K; Wolpin BM; Meyerhardt JA; Wu K; Chan AT; Hollis BW; Giovannucci EL; Stampfer MJ; Willett WC; Fuchs CS
    Br J Cancer; 2009 Sep; 101(6):916-23. PubMed ID: 19690551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
    Stolzenberg-Solomon RZ; Jacobs EJ; Arslan AA; Qi D; Patel AV; Helzlsouer KJ; Weinstein SJ; McCullough ML; Purdue MP; Shu XO; Snyder K; Virtamo J; Wilkins LR; Yu K; Zeleniuch-Jacquotte A; Zheng W; Albanes D; Cai Q; Harvey C; Hayes R; Clipp S; Horst RL; Irish L; Koenig K; Le Marchand L; Kolonel LN
    Am J Epidemiol; 2010 Jul; 172(1):81-93. PubMed ID: 20562185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
    Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
    Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.
    Luo J; Iwasaki M; Inoue M; Sasazuki S; Otani T; Ye W; Tsugane S;
    Cancer Causes Control; 2007 Aug; 18(6):603-12. PubMed ID: 17401636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 25-hydroxyvitamin D levels and the risk of mortality in the general population.
    Melamed ML; Michos ED; Post W; Astor B
    Arch Intern Med; 2008 Aug; 168(15):1629-37. PubMed ID: 18695076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and pancreatic cancer risk in two prospective cohort studies.
    Hamada T; Khalaf N; Yuan C; Babic A; Morales-Oyarvide V; Qian ZR; Nowak JA; Ng K; Kraft P; Rubinson DA; Stampfer MJ; Giovannucci EL; Fuchs CS; Ogino S; Wolpin BM
    J Gastroenterol; 2018 Aug; 53(8):959-966. PubMed ID: 29362938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
    Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
    Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.
    Wolpin BM; Ng K; Bao Y; Kraft P; Stampfer MJ; Michaud DS; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Cochrane BB; Wactawski-Wende J; Chlebowski RT; Willett WC; Manson JE; Giovannucci EL; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):82-91. PubMed ID: 22086883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer.
    Joh HK; Giovannucci EL; Bertrand KA; Lim S; Cho E
    J Natl Cancer Inst; 2013 May; 105(10):726-32. PubMed ID: 23568327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical activity, obesity, height, and the risk of pancreatic cancer.
    Michaud DS; Giovannucci E; Willett WC; Colditz GA; Stampfer MJ; Fuchs CS
    JAMA; 2001 Aug 22-29; 286(8):921-9. PubMed ID: 11509056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
    Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of physical activity and the risk of pancreatic cancer among women (United States).
    Calton BA; Stolzenberg-Solomon RZ; Moore SC; Schatzkin A; Schairer C; Albanes D; Leitzmann MF
    BMC Cancer; 2008 Feb; 8():63. PubMed ID: 18307811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women.
    Stevens RJ; Roddam AW; Spencer EA; Pirie KL; Reeves GK; Green J; Beral V;
    Int J Cancer; 2009 May; 124(10):2400-5. PubMed ID: 19165860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.
    Yuan C; Qian ZR; Babic A; Morales-Oyarvide V; Rubinson DA; Kraft P; Ng K; Bao Y; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Sesso HD; Buring JE; Cochrane BB; Chlebowski RT; Snetselaar LG; Manson JE; Fuchs CS; Wolpin BM
    J Clin Oncol; 2016 Aug; 34(24):2899-905. PubMed ID: 27325858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study.
    Jiao L; Mitrou PN; Reedy J; Graubard BI; Hollenbeck AR; Schatzkin A; Stolzenberg-Solomon R
    Arch Intern Med; 2009 Apr; 169(8):764-70. PubMed ID: 19398688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition.
    Berrington de González A; Spencer EA; Bueno-de-Mesquita HB; Roddam A; Stolzenberg-Solomon R; Halkjaer J; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Boeing H; Pischon T; Linseisen J; Rohrmann S; Trichopoulou A; Benetou V; Papadimitriou A; Pala V; Palli D; Panico S; Tumino R; Vineis P; Boshuizen HC; Ocke MC; Peeters PH; Lund E; Gonzalez CA; Larrañaga N; Martinez-Garcia C; Mendez M; Navarro C; Quirós JR; Tormo MJ; Hallmans G; Ye W; Bingham SA; Khaw KT; Allen N; Key TJ; Jenab M; Norat T; Ferrari P; Riboli E
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):879-85. PubMed ID: 16702364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture Risk in Relation to Serum 25-Hydroxyvitamin D and Physical Activity: Results from the EPIC-Norfolk Cohort Study.
    Julian C; Lentjes MA; Huybrechts I; Luben R; Wareham N; Moreno LA; Khaw KT
    PLoS One; 2016; 11(10):e0164160. PubMed ID: 27749911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression.
    Jung S; Qian ZR; Yamauchi M; Bertrand KA; Fitzgerald KC; Inamura K; Kim SA; Mima K; Sukawa Y; Zhang X; Wang M; Smith-Warner SA; Wu K; Fuchs CS; Chan AT; Giovannucci EL; Ng K; Cho E; Ogino S; Nishihara R
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1628-37. PubMed ID: 24920642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.